Originalartikel

 2025

• A female adolescent with hyponatremia, seizure, rhabdomyolysis, arterial hypertension and neuropsychiatric symptoms / Jugendliche Patientin mit Hyponatriämie, Krampfanfall, Rhabdomyolyse, arteriller Hypertonie und neuropsyhiatrischen Symptomen Welcker, S., Quittek, F., Stauch, T., Riedel, F., Hellenschmidt, A., Hufnagel-Schmude, A., Meyer, S. Wiener Medizinische Wochenschrift, 175, 402-404 (2025)
• Paternal split-liver transplantation followed by haploidentical hematopoietic cell transplantation in an adult patient with protoporphyria-induced liver failure Stölzel, U., Jost, L., Seehofer, D., Egger-Heidrich, K., Scheuermann, U., Hölig, K., Stauch, T., Kunadt, D., Schuppan, D., Schetelig, J., Wohmann, N., Bornhäuser, M., Stölzel, F. eJHaem, 2025; 6:e21092 https://doi.org/10.1002/jha2.1092
• Binding of established antinuclear antibodies to neurons depends on tissue fixation and underlying autoantigens Li LY, Höltje M, Foverskov Rasmussen H, Halle L, Mayrhofer M, Blüthner M, Prüss H Frontiers in Immunology. Published 10 Oct 2025, doi: 10.3389/fimmu.2025.1674907

2024

• German real-world experience of patients with diverse features of acute intermittentporphyria treated with Givosiran Kubisch, I.; Wohmann, N.; Wissniowski, T.T.; Stauch, T.; Oettel, L.; Diehl-Wiesenecker, E.; Somasundaram, R.; Stölzel, U. J. Clin. Med. 2024, 13, 6779. https://doi.org/10.3390/jcm13226779
• German Porphyria Registry (PoReGer) – Background and Setup Gerischer L., Mainert M., Wohmann N., Kubisch I., Stölzel U., Stauch T., von Wegerer S., Braun F., Weiler-Normann C., Blaschke S., et al. Healtcare 2024, 12, 111. https://doi.org/10.3390/healthcare12010111
• High serum prevalence of autoreactive IgG antibodies against peripheral nerve structures in patients with neurological post-COVID-19 vaccination syndrome Arlt FA, Breuer A, Trampenau E, Boesl F, Kirchner M, Mertins P, Sa´nchez-Sendı´n E, Nasouti M, Mayrhofer M, Blüthner M, Endres M, Prüss H, Franke C. Frontiers in Immunology. Published 02 August 2024, doi: 10.3389/fimmu.2024.1404800

2022

• Heterogeneous molecular behavior in liver tumors (HCC and CCA) of two patients with acute intermittent porphyria Haverkamp T, Bronisch O, Knösel T, Mogler C, Weichert W, Stauch T, Schmid C, Rummeny C, Beyrich MK, Petrides PE Journal of Cancer Research and Clinical Oncology. Published online: 16 October 2022 doi.org/10.1007/s00432-022-04384-5

2021

• Influence of Turkish origin on hematology reference intervals in the German population Mayr F.X., Bertram A., Cario H., Frühwald, M.C., Groß H-J., Groening A., Grützner S., Gscheidmeier T., Hoffmann R., Krebs A., Ruf H-G., Torge A., Woelfle J., Razum O., Rauh M., Metzler M. u. Zierk J. Scientific Reports (2021) 11:21074
• Porphyrien Stölzel U, Stauch T, Kubisch I Internist 62:937–951 (2021); doi.org/10.1007/s00108-021-01066-1 CME Zertifizierte Fortbildung

2020

• High Sensitivity Detection of Anti-DFS70 Antibodies by Radioimmunoprecipitation Assay (RIPA) Seelig CA, Blüthner M, Seelig HP. Clin Lab: 66(5), doi: 10.7754/Clin.Lab.2019.191016. (2020)

2019

• Severe Myasthenic Manifestation of Leptospirosis Associated with New Sequence Type of Leptospira interrogans Tomschik M, Koneczny I, Schötta AM, Scharer S, Smajlhodzic M, Fernandes Rosenegger P, Blüthner M, Höftberger R, Zimprich F, Stanek G, Markowicz M. Emerg Infect Dis. 25(5):968-971 (2019).
• Acute porphyrias: A German monocentric study of the biochemical, molecular genetic and clinical data of 62 families Bronisch O, Stauch T, Haverkamp T, Beykirch MK und Petrides PE Ann Hematol 98(12):2683-2691(2019). doi: 10.1007/s00277-019-03831-7

2018

• Combination of rituximab and abatacept as an exit strategy for repetetive B-cell depletion in children with severe autoimmune disease: a report of three cases Speth F, HInze CH, Schranz P, Miller-Wiegert E, Haefner R Lupus: Oct;27 (12), 1996-1998 (2018)
• Rapid spectrophotometric quantification of urinary porphyrins and porphobilinogen as screening tool for attacks of acute porphyria Lang A, Heckl, C, Vogeser M, Stauch T, Homann C, Hennig G, Sroka R und Stepp H Journal of Biomedical Optics 23(5), 055006 (2018)
• Porphyrien Stölzel U, Stauch T, Doss MO Gastroenterologie up2date 14 (3): 1–14 (2018)

2017

• Pediatric reference intervals for alkaline phosphatase Zierk J, Arzideh F, Haeckel R, Cario H, Frühwald MC, Groß HJ, Gscheidmeier T, Hoffmann R, Krebs A, Lichtinghagen R, Neumann M, Ruf HG, Steigerwald U, Streichert T, Rascher W, Metzler M, Rauh M. Clin Chem Lab Med. 2017 Jan 1;55(1):102-110
• Determination of reference ranges and cut-off values for the creatinine ratios of porphyrin precursors 5-aminolevulinic acid and porphobilinogen for the reliable evaluation of urine spot samples Thomas Stauch, Manfred O. Doss, Petro E. Petrides, Ulrich Stölzel, Michael Vogeser Porphyrins & Porphyrias ICPP 2017 Bordeaux, France: Abstr. 2/58 (2017)

2016

• Pharmacokinetic profile of methotrexate in psoriatic skin via the oral or subcutaneous route using dermal microdialysis showing higher methotrexate bioavailability in psoriasis plaques than in nonlesional skin. Quist SR, Quist J, Birkenmaier J, Stauch T, Gollnick HP JEADV, 30(9):1537-43, (2016)
• Non-invasive detection of iron deficiency by fluorescence measurement of erythrocyte zinc protoporphyrin in the lip Georg Hennig, Christian Homann, Ilknur Teksan, Uwe Hasbargen, Stephan Hasmüller, Lesca M. Holdt, Nadia Khaled, Ronald Sroka, Thomas Stauch, Herbert Stepp, Michael Vogeser, Gary M. Brittenham Nature Communications: 1-8 (2016)

2015

• X-linked protoporphyria: Iron supplementation improves protoporphyrin overload, liver damage and anaemia Landefeld Ch, Kentouche K, Gruhn B, Stauch T, Rößler S, Schuppan D, Whatley SD, Beck JF, Stölzel U Br J Haematol: 1-3 (2015)

2014

• Aceruloplasminaemia: A Family with a Novel Mutation and Long-Term Therapy with Deferasirox Lindner U., Schuppan D., Schleithoff L., Habeck J.-O., Grodde T.,Kirchhof K., Stoelzel U. Hormone and Metabolic Research: 47(4), 303-308 (2014)

2012

• Beta-trace protein in ascites and pleural effusions: limits of CSF leakage detection Dietzel J, Krebs A, Böttcher D, Sieb M, Glocker MO, Lüdemann J, Roser M, Dressel A J Neurotrauma: 29(9), 1817-20 (2012)
• Association of testosterone levels with endothelial function in men: results from a population-based study Empen K, Lorbeer R, Dörr M, Haring R, Nauck M, Gläser S, Krebs A, Reffelmann T, Ewert R, Völzke H, Wallaschofski H, Felix SB Arterioscler Thromb Vasc Biol: 32(2), 481-6 (2012)
• Porphyrien Stölzel U, Stauch T, Doss MO Gastroenterologie up 2 date 8: 235-246 (2012)

2011

• Autoantibodies against inosine-5'-monophosphate dehydrogenase 2--characteristics and prevalence in patients with HCV-infection Seelig HP, Appelhans H, Bauer O, Blüthner M, Hartung K, Schranz P, Schultze D, Seelig CA, Volkmann M. Clin Lab: 57(9-10), 753-65 (2011)
• A genome-wide association study of metabolic traits in human urine Suhre K, Wallaschofski H, Raffler J, Friedrich N, Haring R, Michael K, Wasner C, Krebs A, Kronenberg F, Chang D, Meisinger C, Wichmann HE, Hoffmann W, Völzke H, Völker U, Teumer A, Biffar R, Kocher T, Felix SB, Illig T, Kroemer HK, Gieger C, et al. Nat Genet: 43(6), 565-9 (2011)
• Association between serum testosterone and sex hormone-binding globulin and exercise capacity in men: results of the Study of Health in Pomerania (SHIP) Koch B, Glaser S, Schaper C, Krebs A, Nauck M, Dorr M, Haring R, Volzke H, Felix SB, Ewert R, Wallaschofski H, Friedrich N J Androl: 32(2), 135-43 (2011)
• Autoantibodies against inosine-5'-monophosphate dehydrogenase 2--characteristics and prevalence in patients with HCV-infection Seelig HP, Appelhans H, Bauer O, Blüthner M, Hartung K, Schranz P, Schultze D, Seelig CA, Volkmann M. Clin Lab: 57(9-10), 753-65 (2011)
• Autoantibodies against inosine-5'-monophosphate dehydrogenase 2--characteristics and prevalence in patients with HCV-infection Seelig HP, Appelhans H, Bauer O, Blüthner M, Hartung K, Schranz P, Schultze D, Seelig CA, Volkmann M. Clin Lab: 57(9-10), 753-65 (2011)
• Evaluation of a commercially available rapid urinary porphobilinogen test Vogeser M, Stauch T Clin Chem Lab Med. 49(9): 1491-1494 (2011)

2010

• Evidence for a critical role of ceruloplasmin oxidase activity in iron metabolism of Wilson disease gene knockout mice Merle U, Tuma S, Herrmann T, Muntean V, Volkmann M, Gehrke SG, Stremmel W J Gastroenterol Hepatol: 25, 1144-1150 (2010)
• SLA/LP/tRNP((Ser)Sec) antigen in autoimmune hepatitis: identification of the native protein in human hepatic cell extract Volkmann M, Luithle D, Zentgraf H, Schnölzer M, Fiedler S, Heid H, Schulze-Bergkamen A, Strassburg CP, Gehrke SG, Manns MP J Autoimmun: 34, 59-65 (2010)
• Prosthetic valve endocarditis due to Actinomyces neuii successfully treated with antibiotic therapy Grundmann S, Huebner J, Stuplich J, Koch A, Wu K, Geibel-Zehender A, Bode C, Brunner M J Clin Microbiol: 48(3), 1008-1011 (2010)
• Prevalence, incidence and risk factors of testosterone deficiency in a population-based cohort of men: results from the study of health in Pomerania Haring R, Ittermann T, Völzke H, Krebs A, Zygmunt M, Felix SB, Grabe HJ, Nauck M, Wallaschofski H Aging Male: 13(4), 247-57 (2010)
• Association of circulating IGF-I and IGFBP-3 concentrations and exercise capacity in healthy volunteers: results of the Study of Health in Pomerania Gläser S, Friedrich N, Ewert R, Schäper C, Krebs A, Dörr M, Völzke H, Felix SB, Nauck M, Wallaschofski H, Koch B Growth Horm IGF Res: 20(6), 404-10 (2010)
• Association of serum IGF1 with endothelial function: results from the population-based study of health in Pomerania Empen K, Lorbeer R, Völzke H, Robinson DM, Friedrich N, Krebs A, Nauck M, Reffelmann T, Ewert R, Felix SB, Wallaschofski H, Dörr M Eur J Endocrinol: 163(4), 617-23 (2010)
• Thyroid function tests in patients taking thyroid medication in Germany: Results from the population-based Study of Health in Pomerania (SHIP) Hannemann A, Friedrich N, Haring R, Krebs A, Völzke H, Alte D, Nauck M, Kohlmann T, Schober HC, Hoffmann W, Wallaschofski H BMC Res Notes: 16, 3:227 (2010)
• Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79 Haring R, Völzke H, Steveling A, Krebs A, Felix SB, Schöfl C, Dörr M, Nauck M, Wallaschofski H Eur Heart J: 31(12), 1494-501 (2010)
• Urinary albumin excretion, even within the normal range, predicts an increase in left ventricular mass over the following 5 years Reffelmann T, Dörr M, Völzke H, Friedrich N, Krebs A, Ittermann T, Felix SB Kidney Int: 77(12), 1115-22 (2010)
• Hepatic steatosis is associated with low serum testosterone and high serum DHEAS levels in men Völzke H, Aumann N, Krebs A, Nauck M, Steveling A, Lerch MM, Rosskopf D, Wallaschofski H Int J Androl: 33(1), 45-53 (2010)
• Age- and gender-specific reference ranges for serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 concentrations on the Immulite 2500: results of the Study of Health in Pomerania (SHIP) Friedrich N, Krebs A, Nauck M, Wallaschofski H Clin Chem Lab Med: 48(1), 115-20 (2010)
• Neuromyelitis optica and NMO-IgG in European pediatric patients Huppke P, Blüthner M, Bauer O, Stark W, Reinhardt K, Huppke B, Gärtner J. Neurology: 75(19), 1740-1744 (2010)
• Porphyrien Stölzel U, Stauch T, Doss MO Internist (Berl). 51(12): 1525-1533 (2010)

2009

• Association between serum insulin-like growth factor (IGF) I and IGF binding protein-3 and lung function Gläser S, Friedrich N, Ewert R, Schäper C, Nauck M, Dörr M, Völzke H, Felix SB, Krebs A, Wallaschofski H, Koch B J Clin Endocrinol Metab: 94(7), 2452-8 (2009)
• Identification of Rho-GTPase-activating protein 26 as a novel autoantigen Blüthner M, Appelhans H, Moosbrugger I, Wiemann C, Ludwig J, Seelig HP in: Conrad K, Chan EKL, Fritzler MFJ, Humbel RL, von Landenberg P, Shoenfeld Y (Hrsg): From pathogenesis to therapy of autoimmune diseases. Report on the 9th Dresden Symposium on autoantibodies: 108-109 (2009)
• Identification of Inosine-1,2-Monophosphate dehydrogenase as a novel autoantigen. Blüthner M, Appelhans H, Moosbrugger I, Wiemann C,Lenz D, Seelig HP in: Conrad K, Chan EKL, Fritzler MJ, Humbel RL, Landenberg von P, Shoenfeld Y, (Hrsg): From pathogenesis to therapy of autoimmune diseases . Report on the 9th Dresden Symposium on autoantibodies: 106-107 (2009)
• Safe and probably safe drugs in acute hepatic porphyria Stölzel U, Brosche C, Koszka C, Stauch T, Teubner A, Doss MO Cell Mol Biol: 55(2), 147-151 (2009)
• Arzneistoffe bei akuten hepatischen Porphyrien und Empfehlungen zur Anästhesie Doss MO, Stölzel U, Doss-Frank M, Stauch T Rote Liste 2009: Rote Liste Service GmbH, Frankfurt/M., 615-616 (2009)

2008

• Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis Bochtler T, Hegenbart U, Heiss C, Benner A, Cremer F, Volkmann M, Ludwig J, Perz JB, Ho AD, Goldschmidt H, Schönland SO Haematologica: 93, 459-462 (2008)
• Reference ranges for serum dehydroepiandrosterone sulfate and testosterone in adult men Friedrich N, Völzke H, Rosskopf D, Steveling A, Krebs A, Nauck M, Wallaschofski H Androl: 29(6), 610-7 (2008)
• Neutrophils in cerebrospinal fluid without pleocytosis Dietzel J, Krebs A, Lüdemann J, Roser M, Dressel A Eur J Neurol: 15(6), 634-6 (2008)
• Five commercially available insulin-like growth factor I (IGF-I) assays in comparison to the former Nichols Advantage IGF-I in a growth hormone treated population Krebs A, Wallaschofski H, Spilcke-Liss E, Kohlmann T, Brabant G, Völzke H, Nauck M Clin Chem Lab Med: 46(12), 1776-83 (2008)
• Theoretical and experimental evaluation of a CYP106A2 low homology model and production of mutants with changed activity and selectivity of hydroxylation Lisurek M, Simgen B, Antes I, Bernhardt R Chembiochem: 9(9), 1439-1449 (2008)
• Inter-laboratory survey of erythrocyte free protoporphyrin quantification - announcement of a pilot study Vogeser M, Müller W, Stauch T Clin Chem Lab Med: 46(9), 1340-1 (2008)

2007

• Labordiagnostik bei Erkrankungen der Bauchspeicheldrüse Volkmann M DHZ: 5, 16-18 (2007)
• Impaired coronary function in Wistar Ottawa Karlsburg W rats-a new model of the metabolic syndrome Grisk O, Frauendorf T, Schlüter T, Klöting I, Kuttler B, Krebs A, Lüdemann J, Rettig R Pflugers Arch: 454(6), 1011-21 (2007)
• Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica Paul F, Jarius S, Aktas O, Blüthner M, Bauer O, Appelhans H, Franciotta D, Bergamaschi R, Littleton E, Palace J, Seelig HP, Hohlfeld R, Vincent A, Zipp F PLoS Med: 4(4), e133 (2007)
• Akute porphyrische Attacke mit vegetativer Krise, zerebraler Beteiligung und hochgradiger Polyneuropathie Baeuerle J, Stauch T, Roesel TH, Esser W, Druschky KF 80. Kongress der Deutschen Gesellschaft für Neurologie: P 429, Berlin 12.-15.09.2007 (2007)
• Liver Cirrhosis in a six-year-old boy with Protoporphyria Stoelzel U, Habeck JO, Roessler S, Doss MO, Stauch T, Koestler E Porphyrins & Porphyrias, Rotterdam, Netherlands: Abstr. P29 / 103 (2007)
• Biochemical compared to molecular genetic analyses in acute hepatic porphyrias Stauch T, Gross U, Doss-Frank M, Doss MO Porphyrins & Porphyrias, Rotterdam, Netherlands: Abstr. P10 / 83 (2007)

2006

• Lentiviral gene transfer ameliorates disease progression in Long-Evans cinnamon rats: an animal model for Wilson disease Merle U, Encke J, Tuma S, Volkmann M, Naldini L, Stremmel W Scand J Gastroenterol: 41, 974-982 (2006)
• Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumormarkers Müller M, Meyer M, Schilling T, Ulsperger E, Lehnert T, Zentgraf H, Stremmel W, Volkmann M, Galle PR Int J Oncol: 29, 973-980 (2006)
• Function and engineering of the 15beta-hydroxylase CYP106A2 Virus C, Lisurek M, Simgen B, Hannemann F, Bernhardt R Biochem Soc Trans: 34(Pt 6), 1215-1218 (2006)

2005

• Recurrent bacteraemia by 2 different Bacillus cereus strains related to 2 distinct central venous catheters Koch A, Arvand M Scand J Infect Dis: 37(10), 772-774 (2005)
• Evaluation of the Glucometer Elite XL device for screening for neonatal hypoglycaemia Michel A, Küster H, Krebs A, Kadow I, Paul W, Nauck M, Fusch C Eur J Pediatr: 164(11), 660-4 (2005)
• Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen Mahler M, Raijmakers R, Dähnrich C, Blüthner M, Fritzler MJ Arthritis Res Ther: 7(3), 704-713 (2005)
• Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies Mahler M, Fritzler MJ, Blüthner M Arthritis Res Ther: 7(1), 19-29 (2005) Publikationen Dr. rer. nat. Martin Blüthner MVZ Labor PD Dr. Volkmann und Kollegen GbR 2
• Variegate Porphyria versus PCT and Acne: Pitfalls in Diagnosis and Treatment Stauch T, Doss-Frank M, Doss MO Porphyrins & Porphyrias, Cape Town, South Africa: Abstr. 4 / 41 (2005)

2004

• Serum protein electrophoresis: reptilase treatment is superior to ethanolprecipi-tation for specific removal of fibrinogen from heparinized plasma samples Ibrahim Y, Volkmann M, Hassoun R, Fiehn W, Rossmann H Clin Chem: 50, 1100-1101 (2004)
• Guanylin regulates chloride secretion in the human gallbladder via the bile fluid Kulaksiz H, Schlenker T, Rost D, Stiehl A, Volkmann M , Lehnert T, Cetin Y, Stremmel W Gastroenterology: 126(3), 732-740 (2004)
• Iron overload in adult Hfe-deficient mice independent of changes in the steady-state expression of the duodenal iron transporters DMT1 and Ireg1/ferroportin Herrmann T, Muckenthaler M, van der Hoeven F, Brennan K, Gehrke SG., Hubert N, Sergi C, Gröne HJ, Kaiser I, Gosch I, Volkmann M, Riedel HD, Hentze MW, Stewart AF, Stremmel W J Mol Med: 82(1), 39-48 (2004)
• Reduced colonization and infection with miconazole-rifampicin modified central ve-nous catheters: a randomized controlled clinical trial Yücel N, Lefering R, Maegele M, Max M, Rossaint R, Koch A, Schwarz R, Korenkov M, Beuth J, Bach A, Schierholz J, Pulverer G, Neugebauer EA J Antimicrob Chemother: 54(6), 1109-1115 (2004)
• The third case of Doss porphyria (d-Aminolevulinic acid dehydratase deficiency) in Germany Doss MO, Stauch T, Gross U, Renz M, Doss-Frank M, Seelig HP, Sassa S J Inherit Metab Dis: 27, 529-536 (2004)

2003

• Cerebrospinal fluid tau levels in Alzheimer‘s disease are elevated when compared to vascular dementia but do not correlate with measures of cerebral atrophy Schönknecht P, Pantel J, Hartmann T, Werle E, Volkmann M, Essig M, Amann M, Zanabili N, Bardenheuer H, Hunt A, Schröder J Psychiatry Res: 120, 231-238 (2003)
• Levels of total tau and tau protein phosphorylated at threonine 181 in patients with incipient and manifest Alzheimer's disease Schönknecht P, Pantel J, Hunt A, Volkmann M, Buerger K, Hampel H, Schröder J Neurosci Lett: 339, 172-174 (2003)
• Cerebrospinal fluid tau protein levels in schizophrenia Schönknecht P, Hempel A, Hunt A, Seidl U, Volkmann M, Pantel J, Schröder J Eur Arch Psychiatry Clin Neurosci: 253, 100-102 (2003)
• Advances in B-cell epitope analysis of autoantigens in connective tissue diseases Mahler M, Blüthner M, Pollard KM Clin Immunol: 107(2), 65-79 (2003)
• Recombinant anti-P protein autoantibodies isolated from a human autoimmune library: reactivity, specificity and epitope recognition Zampieri S, Mahler M, Blüthner M, Qiu Z, Malmegrim K, Ghirardello A, Doria A, van Venrooij WJ, Raats JM Cell Mol Life Sci: 60(3), 588-598 (2003)
• Characterization of the human autoimmune response to the major C-terminal epitope of the ribosomal P proteins Mahler M, Kessenbrock K, Raats J, Williams R, Fritzler MJ, Blüthner M J Mol Med: 81(3), 194-204 (2003)
• Acute Hepatic Porphyrias without Detectable Genetic Defects Stauch T, Renz M, Seelig HP, Doss MO Porphyrins & Porphyrias, Prague, Czech Republic: Abstr. 54 / 25S (2003)

2002

• Anti-p53 in breast cancer: concordance of different assay procedures and association with p53 antigen expression Volkmann M, Sinn HP, Gaugel D, Frey M, Hajjar Y, Ludwig J, Hänsel S, Bastert G, Wallwiener D, Fiehn W, Zentgraf H, Huober J Oncology: 63, 297-305 (2002)
• Prognostische Wertigkeit des Antikörpernachweises gegen p53 bei Patienten mit Plattenepithelkarzinomen der Mundhöhle anhand der 5-Jahresuberlebensrate Hofele C, Schwager-Schmidt M, Volkmann M Laryngo-Rhino-Otologie: 81(5), 342-345 (2002)
• Development of a CENP-A/CENP-B-specific immune response in a patient with systemic sclerosis Mahler M, Mierau R, Genth E, Blüthner M Arthritis Rheum: 46(7), 1866-1872 (2002)

2001

• Study of p53 gene mutation in hepatocellular carcinoma patients from China Kang G, Fang Z, Volkmann M Chinese J Exp Clin Virol: 15, 163-165 (2001)
• Soluble liver antigen: isolation of a 35 kD recombinant protein (SLA-P35) specifically recognizing sera from patients with autoimmune hepatitis Volkmann M, Martin L, Bäurle A, Heid H, Strassburg CP, Trautwein C, Fiehn W, Manns MP Hepatology: 33, 591-596 (2001)
• Loss of CD95 expression is linked to most but not all p53 mutants in European hepatocellular carcinoma Volkmann M, Schiff JH, Hajjar Y, Otto G, Stilgenbauer F, Hofmann WJ, Otto G, Fiehn W, Galle PR, Hofmann WJ J Mol Med: 79, 594-600 (2001)
• A population of autoantibodies against a centromere-associated protein A major epitope motif cross-reacts with related cryptic epitopes on other nuclear autoantigens and on the Epstein-Barr nuclear antigen 1 Mahler M, Mierau R, Schlumberger W, Blüthner M J Mol Med: 79(12), 722-731 (2001)

2000

• Immunoreactivity to cytokeratin 8/18 in patients with soluble liver antigen (SLA) positive autoimmune hepatitis is not sufficient for diagnostic use Martin L, Bäurle A, Fiehn W, Volkmann M Clin Lab: 46, 339-344 (2000)
• Pair of siblings of Italian ethnicity with hyperferritinemia and cataract Volkmann M, Schiff HJ, Hör M, Hentze MW, Fiehn W, Merkt J Internist-Berl: 41, 381-384 (2000)
• Zementierte Hüftendoprothetik-Verminderung des Fettembolierisikos mittels gepulster Druckspülung Breusch SJ, Reitzel T, Schneider U, Volkmann M, Ewerbeck V, Lukoschek M Orthopäde: 29, 578-586 (2000)
• Neuron-specific enolase as a marker of fatal outcome in patients with severe sepsis or septic shock Weigand MA, Volkmann M, Schmidt H, Martin E, Bohrer H, Bardenheuer HJ Anaesthesiology: 92, 905-907 (2000)
• Substrate binding to 15beta-hydroxylase (CYP106A2) probed by FT infrared spectroscopic studies of the iron ligand CO stretch vibration Simgen B, Contzen J, Schwarzer R, Bernhardt R, Jung C Biochem Biophys Res Commun: 269(3), 737-742 (2000)
• Fine-specificity of the anti-CENP-A B-cell autoimmune response Mahler M, Mierau R, Blüthner M J Mol Med:78(8), 460-467 (2000)
• Proteolytic cleavage of a self-antigen following xenobiotic-induced cell death produces a fragment with novel immunogenic properties Pollard KM, Pearson DL, Blüthner M, Tan EM J Immunol: 165(4), 2263-2270 (2000)
• G(-699)/C polymorphism in the bradykinin-1 receptor gene in patients with renal failure Knigge H, Blüthner M, Brüntgens A, Sator H, Ritz E Nephrol Dial Transplant: 15(5), 586-588 (2000)
• Identification of an alpha-helical epitope region on the PM/Scl-100 autoantigen with structural homology to a region on the heterochromatin p25beta autoantigen using immobilized overlapping synthetic peptides Blüthner M, Mahler M, Müller DB, Dünzl H, Bautz FA J Mol Med:78(1), 47-54 (2000)

1999

• Platelet activation as a potential mechanism of GP IIb/IIIa inhibitor induced thrombocytopenia Peter K, Straub A, Kohler B, Volkmann M, Schwarz M, Kübler W, Bode C Am J Cardiol: 84, 519-524 (1999)
• CDKN2 mutation is infrequent in German hepatocellular carcinoma Volkmann M, Stilgenbauer F, Hofmann WJ, Otto G, Schiff JH, Fiehn W Oncology: 57, 306-310 (1999)
• Loss of wild-type MEN1 gene expression in multiple endocrine neoplasia type 1-associated parathyroid adenoma Ludwig L, Schleithoff L, Kessler H, Wagner PK, Boehm BO, Karges W Endocr J: 46(4), 539-544 (1999)
• Genomic structure and functional expression of a human alpha(2)/delta calcium channel subunit gene(CACNA2) Schleithoff L, Mehrke G, Reutlinger B, Lehmann-Horn F Genomics: 61(2), 201-209 (1999))
• Screening of the ryanodine receptor gene in 105 malignant hyperthermia families: novel mutations and concordance with the in vitro contracture test Brandt A, Schleithoff L, Jurkat-Rott K, Klingler W, Baur C, Lehmann-Horn F Hum Mol Genet: 8(11), 2055-2062 (1999)
• A reduced K+ current due to a novel mutation in KCNQ2 causes neonatal convulsions Lerche H, Biervert C, Alekov AK, Schleithoff L, Lindner M, Klinger W, Bretschneider F, Mitrovic N, Jurkat-Rott K, Bode H, Lehmann-Horn F, Steinlein OK Ann Neurol: 46(3), 305-312 (1999)
• Increased frequency of G-protein beta 3-subunit 825 T allele in dialyzed patients with type 2 diabetes Blüthner M, Schmidt S, Siffert W, Knigge H, Nawroth P, Ritz E Kidney Int: 55(4), 1247-1250 (1999)
• Identification of major linear epitopes on the sp100 nuclear PBC autoantigen by the gene-fragment Publikationen Dr. rer. nat. Martin Blüthner MVZ Labor PD Dr. Volkmann und Kollegen GbR 3
• phage-display technology Blüthner M, Schäfer C, Schneider C, Bautz FA Autoimmunity: 29(1), 33-42 (1999)
• Association of methylenetetrahydrofolate reductase gene polymorphism and diabetic nephropathy in type 2 diabetes? Blüthner M, Brüntgens A, Schmidt S, Strojek K, Grzeszczak W, Ritz E Nephrol Dial Transplant: 14(1), 56-57 (1999)
• Nucleotide sequence of a new HLA-DQB1 allele, DQB1*03033 Schranz P, Renz M, Seelig R, Seelig HP Tissue Antigens: 54(3), 310-311 (1999)

1998

• Hepatic failure and liver cell damage in acute Wilson‘s disease involve CD95 (Apo-1/Fas) mediated apoptosis Strand S, Hofmann WJ, Grambihler A, Hug H, Volkmann M, Otto G, Wesch H, Mariani S, Hack V, Stremmel W, Krammer PH, Galle PR Nature Medicine: 4(5), 588-593 (1998)
• Fecal eleastase 1, chymotrypsin and fecal fat analysis: comparison in a routine laboratory setting Volkmann M, Hackenberg M, Schiff JH, Fiehn W Clin Lab: 44, 989-995 (1998)
• Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferation Emig R, Magener A, Ehemann V, Meyer A, Stilgenbauer F, Volkmann M, Wallwiener D, Sinn HP Br J Cancer: 78(12), 1661-1668 (1998)
• Transient weakness and compound muscle action potential decrement in myotonia congenita Deymeer F, Cakirkaya S, Serdaroglu P, Schleithoff L, Lehmann-Horn F, Rüdel R, Ozdemir C Muscle Nerve: 21(10), 1334-1337 (1998)
• The dominant chloride channel mutant G200R causing fluctuating myotonia: clinical findings, electrophysiology, and channel pathology Wagner S, Deymeer F, Kürz LL, Benz S, Schleithoff L, Lehmann-Horn F, Serdaroglu P, Ozdemir C, Rüdel R Muscle Nerve: 21(9), 1122-1128 (1998)
• An oncogenic fusion product of the phosphatidylinositol 3-kinase p85beta subunit and HUMORF8, aputative deubiquitinating enzyme Janssen JW, Schleithoff L, Bartram CR, Schulz AS Oncogene: 16(13), 1767-72 (1998)
• A polymorphism in the gene for the atrial natriuretic peptide and diabetic nephropathy. Diabetic Nephropathy Study Group Schmidt S, Blüthner M, Giessel R, Strojek K, Bergis KH, Grzeszczak W, Ritz E Nephrol Dial Transplant: 13(7), 1807-1810 (1998)

1997

• Intracellular signaling of the Ufo/Axl receptor tyrosine kinase is mediated mainly by a multi-substrate docking-site Schleithoff L, Braunger J, Schulz AS, Kessler H, Lammers R, Ullrich A, Bartram CR, Janssen JW Oncogene: 14(22), 2619-2631 (1997)
• Functional characterization of a distinct ryanodine receptor mutation in human malignant hyperthermia-susceptible muscle Richter M, Schleithoff L, Deufel T, Lehmann-Horn F, Herrmann-Frank A J Biol Chem: 272(8), 5256-5260 (1997)
• The autoimmunity-inducing xenobiotic mercury interacts with the autoantigen fibrillarin and modifies its molecular and antigenic properties Pollard KM, Lee DK, Casiano CA, Blüthner M, Johnston MM, Tan EM J Immunol: 158(7), 3521-3528 (1997)
• Nucleotide sequence of a new HLA DQA1*06 allele (DQA1*06012) Schranz P, Albert ED, Renz M, Seelig R, Seelig HP Tissue Antigens: 50(6), 693-694 (1997)
• Solvent and Other Effects on the Stereoselctivity of Thioglycoside Glycosidations Stauch T, Demchenko A, Boons GJ Synlett: 7, 818-820 (1997)

1996

• Use of specific ELISA for the detection of antibodies directed against p53 protein in patients with hepatocellular carcinoma Ryder SD, Rizzi PM, Volkmann M, Metevier E, Perreira LM, Galle PR, Naoumov N, Zentgraf H, Williams R J Clin Path: 49(4), 295-299 (1996)
• Mutational analysis of the Epstein-Barr virus nuclear antigen 2 by far-Western blotting and DNA-binding studies Sauder C, Götzinger N, Schubach WH, Horvath GC, Kremmer E, Krebs A, König S, Zimber Strobl U, Mueller Lantzsch N, Grässer FA J Gen Virol: 77(Pt 5), 991-6 (1996)
• Mapping of epitopes recognized by PM/Scl autoantibodies with gene-fragment phage display libraries Blüthner M, Bautz EK, Bautz FA J Immunol Methods: 198(2), 187-198 (1996)
• Nucleotide sequence of the corrected DQB1*06011 allele Schranz P, Nessler G, Schindera F, Seelig R Tissue Antigens: 48(2), 139-140 (1996)
• Nucleotide sequence of a new HLA-DPB1 allele, DPB1*02013 Schranz P, Renz M, Wojtzyk I, Seelig R Immunogenetics: 44(2), 159-160 (1996)
• Nucleotide sequence of a new HLA-DRB1(*)11 allele (DRB1(*)1124) Schranz P, Seelig R, Seidl C, Renz M Immunogenetics: 43(4), 242-243 (1996)
• Stereoselectivity in Glycosidic Bond Formation: Studies on the Anomerisation of Thioglycosides Stauch T, Boons GJ Synlett: 6, 906-908 (1996)
• A Critical Evaluation of the Cationic Coupling of 4-Acetoxy-1,3-dioxanes Boons GJ, Eveson R, Smith S, Stauch T Synlett: 6, 536-538 (1996)

1995

• P53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias Döhner H, Fischer K, Bentz M, Hansen K, Benner A, Cabot G, Diehl D, Schlenk R, Coy J, Stilgenbauer S, Volkmann M, Galle PR, Poustka A, Hunstein W, Lichter P Blood: 85(6), 1580-1589 (1995)
• Cleavage of DNA topoisomerase I (Scl-70 autoantigen) during apoptosis Casiano CA, Pollard KM, Blüthner M, Tan EM, Martin SJ Arthritis Rheum: 38, S319 (1995)

 Synthesis of Ganglioside GM1 via a GA1-Intermediate Stauch T, Greilich U, Schmidt RR Liebigs Ann Chem: 2101-2111 (1995)

1994

• Genetic heterogeneity of hepatocellular carcinoma Unsal H, Yalkicier Y, Marcais C, Kew M, Volkmann M, Zentgraf H, Isselbacher K, Öztürk M Proc Natl Acad Sci USA: 91, 822-826 (1994)
• Clinical implications of the p53 tumor suppressor gene Müller M, Volkmann M, Zentgraf H, Galle PR New Engl J Med: 330, 864-865 (1994)
• P53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation Volkmann M, Hofmann WJ, Müller M, Räth U, Otto G, Kommerell B, Zentgraf H, Galle PR Oncogene: 9, 195-204 (1994)
• In vitro experimental infection of primary human hepatocytes with hepatitis B virus Galle PR, Hagelstein J, Kommerell B, Volkmann M, Schranz P, Zentgraf H Gastroenterology: 106, 464-473 (1994)
• P53 autoantibodies in malignant disease: Significance and clinical relevance Galle PR, Volkmann M Klin Lab: 12(40), 1193-1197 (1994)
• Detection of p53-antibodies by Immunoblot and ELISA in various human malignancies- a new serological test? Galle PR, Müller M, Zentgraf H, Volkmann M in: R.Klapdor (ed). Current Tumor Diagnosis: Applications, Clinical Relevance, Research Trends W. Zuckerschwerdt Verlag München, New York: 562-564 (1994)
• Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell Bock CT, Schranz P, Schröder CH, Zentgraf H Virus Genes: 8(3), 215-229 (1994)
• Molecular genetic analyses of a 376-kilodalton Golgi complex membrane protein (giantin) Seelig HP, Schranz P, Schröter H, Wiemann C, Griffiths G, Renz M Mol Cell Biol: 14(4), 2564-2576 (1994). Retraction in: Mol Cell Biol: 15(1), 591 (1995)
• In vitro experimental infection of primary human hepatocytes with hepatitis B virus. Galle PR, Hagelstein J, Kommerell B, Volkmann M, Schranz P, Zentgraf H Gastroenterology: 106(3), 664-673 (1994)
• Macrogolgin-a new 376 kD Golgi complex outer membrane protein as target of antibodies in patients with rheumatic diseases and HIV infections. Publikationen Dr. rer. nat. Peter Schranz MVZ Labor PD Dr. Volkmann und Kollegen GbR 2 Seelig HP, Schranz P, Schröter H, Wiemann C, Renz M J Autoimmun: 7(1), 67-91 (1994)

1993

• Co-localisation of the tumor suppressor protein p53 and human papillomavirus E6 protein in human cervical carcinoma cell lines Liang XH, Herman B, Volkmann M, Klein R, Lockett S Oncogene: 8, 2645-2652 (1993)
• The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status Volkmann M, Müller M, Hofmann WJ, Meyer M, Hagelstein J, Räth U, Kommerell B, Zentgraf H, Galle PR Hepatology: 18(9), 559-565 (1993)
• Multiparameter approach in the identification of cross-contaminated leukemia cell lines Gignac SM, Steube K, Schleithoff L, Janssen JW, MacLeod RA, Quentmeier H, Drexler HG Leuk Lymphoma: 10(4-5), 359-368 (1993)
• A PvuII-polymorphism within the AXL gene on chromosome 19q13.1 Linz U, Schleithoff L, Janssen JW, Bartram CR, Müller CR Hum Mol Genet: 2(4), 492 (1993)
• The genomic structure of the human UFO receptor Schulz AS, Schleithoff L, Faust M, Bartram CR, Janssen JW Oncogene: 8(2), 509-513 (1993)
• The LIM-motif of the human T-cell translocation deregulated gene (TTG-2) takes part in protein-protein interaction Wildhart G, Blüthner M, Bodem J, Royer-Pokora BJournal of Cancer Research and Clinical Oncology: Suppl. 2, 119 (1993)

1992

• Überexpression eines aberranten p53 beim hepatozellulären Karzinom nach Punktmutation des p53 Tumorsuppressorgens Galle PR, Räth U, Hofmann WJ, Zentgraf H, Volkmann M Innere Medizin: 19, 37-40 (1992)
• Differences in DNA fingerprints of continuous leukemia-lymphoma cell lines from different sources Haene B, Tümmler M, Jäger K, Schleithoff L, Janssen JW, Drexler HG Leukemia: 6(11), 1129-1133 (1992)
• The murine ufo receptor: molecular cloning, chromosomal localization and in situ expression analysis Faust M, Ebensperger C, Schulz AS, Schleithoff L, Hameister H, Bartram CR, Janssen JW Oncogene: 7(7), 1287-1293 (1992)
• Cloning and characterization of the cDNA coding for a polymyositis-scleroderma overlap syndrome-related nucleolar 100-kD protein Blüthner M, Bautz FA J Exp Med: 176(4), 973-978 (1992)
• Stereoselective Synthesis of Complex Glycosphingolipids -Studies on Sialylation Methods Brescello R, Greilich U, Martin T, Stauch T, Toepfer A, Schmidt RR XVIth Int Carbohydr Symp, Paris, France: Abstr. A 225 (1992)

1991

•  P53 mutation in hepatocellular carcinoma after Aflatoxin exposure Öztürk M, Bressac B, Puisieux A, Kew M, Volkmann M, Bozcall S, Bella Mura J, Carlson R, Blum HE, v. Weizsäcker F, Galun E, Kar S, Schröder CH, Erken E, Varinli S, Rustgi VK, Prat J, Toda G, Koch HK, Liang XH, Thang XY, Shouval D Lee, HS, Vyas GN, Sarosi I The Lancet: 338, 1356-1359 (1991)

1990

• Changes in clonal growth, immunophenotype and morphology during a follow-up study of ALL Reichle A, Volkmann M, Pachmann K, Diddens H, Emmerich B Haematology and blood transfusion: 33, 159-165 (1990)
•  Antigen receptor rearrangement and expression in acute leucemias Volkmann M, Mar P, Pachmann K, Thiel E, Emmerich B Haematology and blood transfusion: 33, 50-55 (1990)

1989

•  Molekularbiologie und Prognose bei Non Hodgkin-Lymphomen niedriger Malignität Emmerich B, Pachmann K, Volkmann M, Kersten W in: Non-Hodgkin-Lymphome: Trends in der Diagnostik und Therapie. Onkologisches Kolloquium 3, Berlin (1989)

Buchbeiträge

2022

• Disorders of heme metabolism Stölzel U, Kubisch I, Stauch T and Schuppan D in: Blau N, Dionisi Vici C, Ferreira C, Vianey-Saban C, van Karnebeek C (Editors): Physician’s Guide to the Diagnosis, Treatment and Follow-up of Inherited Metabolic Diseases. Springer: 1115-1128 (2. Ed., 2022)

2021

• Porphyrien Stölzel U, Kubisch I, Stauch T in: Sauerbruch T (Hrsg): Therapie-Handbuch Gastroenterologie und Hepatologie, Elsevier: 413-423 (1. Aufl. 2021)

2019

• Stauch T in: Gressner AM, Arndt T (Hrsg): Lexikon der Medizinischen Laboratoriumsdiagnostik, 3. Aufl. 2019, Springer: Verschiedene lexikalische Stichworteinträge in 3 Bänden

2014

• Akute Porphyrien Stölzel U, Stauch T, Lindner U, Doss MO in: G. Marx et al. (Hrsg): Die Intensivmedizin, Springer: 913-936 (2014)
• Akute Porphyrien Stölzel U, Stauch T, Doss MO in: Dahl S. vom et al. (Hrsg): Angeborene Stoffwechselkrankheiten bei Erwachsenen, Springer: 461-468 (2014)
• Heme Synthesis Defects and Porphyrias Stölzel U, Stauch T, Doss MO in: Blau N, Duran M, Gibson KM, Dionisi-Vivi C (Hrsg): Physician’s Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases, Springer: 541-554 (2014)

2002

• Epitope mapping of antibodies with solid-phase oligopeptides Koch J, Mahler M, Blüthner M in: Koch J, Mahler M (Hrsg): Peptide Arrays on Membrane Supports -Synthesis and Applications, Springer Lab Manual: 69-82 (2002)
• Affinity purification and competition assays using solid-phase oligopeptides Mahler M, Blüthner M, Koch J in: Peptide Arrays on Membrane Supports - Synthesis and Applica-tions, Springer Lab Manual: 107-122 (2002)
• Mutational analysis and structure predictions Blüthner M, Mahler M, Koch J in: Peptide Arrays on Membrane Supports - Synthesis and Applica-tions, Springer Lab Manual: 123-140 (2002)
• Modification of immobilized peptides Bodem J, Blüthner M in: Peptide Arrays on Membrane Supports - Synthesis and Applications, Springer Lab Manual: 141-152
• Immobilized peptides to study protein-protein interactions - potentials and pitfalls Bräuning R, Mahler M, Hügle-Dörr B, Blüthner M, Koch J, Petersen G in Peptide Arrays on Membrane Supports - Synthesis and Applications, Springer Lab Manual: 153-164 (2002)

2001

• Analysis of protein interactions with peptides synthesized on membranes Koch J, Mahler M, Blüthner M, Dübel S in: Golemis E, Serebriiskii I: Protein Interactions, Cold Spring Harbor Laboratory Press: 569-581 (2001)

2000

• Advances in B-cell epitope elucidation in patients with sSc (systemic sclerosis Blüthner M, Bautz FA in: Pandalai SG (Hrsg): Recent Research Developments in Immunology: 2 Part I, 249-264 (2000)

1998

• Methods in immunolocalization of autoantigens Blüthner M in: Schenkel J (Hrsg): RNP particles, splicing and autoimmune diseases, Springer Lab Manual: 155-193 (1998)

1994

• The PM/Scl antigens Bautz FA, Blüthner M in: Venrooij van WJ, Maini RN (Hrsg): Manual of Biological Markers of Disease, Kluwer Academic Publishers: B 5.4/1-B 5.4/17 (1994)

Patentschrift

2000

• Method of detecting p53-specific antibodies H. Zentgraf, P. Schranz, M. Volkmann, C. Tessmer, R. Klein; Deutsches Krebsforschungszentrum, Stiftung öffentlichen Rechts, Heidelberg US Patent 6,051,384 (18. 4. 2000)

Gene

2006

•  Gene symbol: PRSS1. Disease: Pancreatitis,hereditary. Accession #Hm0542 Schleithoff L, Seelig HP Hum Genet: 118(6), 779 (2006)
•  Gene symbol: TNFSF5. Disease: Hyper-IgM syndrome. Accession #Hm0539 Schleithoff L, Seelig HP Hum Genet: 118(6), 778 (2006)
•  Gene symbol: SERPINC1. Disease: Antithrombin deficiency. Accession #Hd0514 Schleithoff L, Seelig HP Hum Genet: 118(6), 775 (2006)